ImmunogenX is a clinical-stage company founded in 2013 and supported by a team of world-renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease.


Pharmaceutical

ImmunogenX

ImmunogenX's headquarters in Newport Beach, CA, United States

Jack A. Syage

Jennifer Sealey-Voyksner

Joseph A. Murray

Ciarán P. Kelly

Jack Henion

Janice Soreth

Peter H. R. Green

Markku Mäki

Chaitan Khosla

This department oversees strategic direction and decision-making within the organization.

Leadership Management

The Leadership Team at ImmunogenX is responsible for setting the strategic direction of the company, guiding the development of innovative treatments for celiac disease, and fostering collaboration among scientists and industry partners. They leverage their extensive expertise to drive clinical advancements, ensure operational efficiency, and fulfill the company's mission to improve the lives of individuals affected by this condition.

Leadership Team

This department provides expert guidance and support in scientific research and policy matters.

ImmunogenX

Org chart

Board & advisors

Teams

Leadership Management

Leadership Team

Scientific Affairs

Offices

ImmunogenX

Org chart

Board & advisors

Teams

Leadership Management

Leadership Team

Scientific Affairs

Offices

Related companies